Completed PHASE4 INTERVENTIONAL 2-arm NCT03151603

Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial (REGATTA)

Sponsor: University Medical Center Goettingen

Interventions Arctuvan Fosfomycin Placebo to Arctuvan Placebo to Fosfomycin

Updated 8 times since 2017 Last updated: Nov 26, 2019 Started: May 3, 2017 Primary completion: May 19, 2019 Completion: Jun 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Urinary Tract Infections, this trial is completed. The trial is conducted by University Medical Center Goettingen and has accumulated 8 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 3 earlier versions

Mar 2019 — Dec 2019 [monthly]

Recruiting PHASE4
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE4
Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center Goettingen

Data source: University Medical Center Goettingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Achim, Germany , Braunschweig, Germany , Bremen, Germany , Burgwedel, Germany , Celle, Germany , Emmerthal, Germany , Gieboldehausen, Germany , Gillersheim, Germany , Göttingen, Germany , Hanover, Germany and 23 more locations